Condition: Carcinoma Breast · Triple-negative Breast Cancer · Invasive Ductal Carcinoma, Breast · Sponsor: Fudan University
This is a prospective, multicenter, randomized, parallel controlled, open-label study. The primary purpose of this study is to evaluate the efficacy of Huaier Granule on postoperative adjuvant therapy of high-risk early-stage triple-negative invasive ductal carcinoma. The Secondary purposes are to evaluate the safety of long-term use of Huaier granules as postoperative adjuvant treatment of high-risk early-stage triple-negative invasive ductal carcinoma, and the changes of quality of life score after treatment with Huaier granule.
This description comes directly from the study's public registry record.
Zhimin Shao, PhD · +86-18017312288 · zhimingshao@yahoo.com
Liang Huang, PhD · +86-18121299334 · fdhlyx@163.com
Always discuss trial participation with your own doctor first.
| The First Affiliated Hospital of Anhui Medical University | Hefei, Anhui, China | Recruiting |
| The First Affiliated Hospital of USTC, Anhui Provincial Hospital | Hefei, Anhui, China | Recruiting |
| Cancer Hospital Chinese Academy of Medical Science | Beijing, Beijing Municipality, China | Recruiting |
| The Second Affiliated Hospital of Chongqing Medical University | Chongqing, Chongqing Municipality, China | Recruiting |
| Fujian Cancer Hospital | Fuzhou, Fujian, China | Recruiting |
| Guangdong Provincial Hospital of Traditional Chinese Medicine | Guangzhou, Guangdong, China | Recruiting |
| Guangdong Provincial People's Hospital | Guangzhou, Guangdong, China | Recruiting |
| The Fourth Hospital of Hebei Medical University, Hebei Tumor Hospital | Shijiazhuang, Hebei, China | Recruiting |
| The First Affiliates Hospital of Ha'erbin University | Harbin, Heilongjiang, China | Recruiting |
| Henan Provincial People's Hospital | Zhengzhou, Henan, China | Recruiting |
| Hubei Cancer Hospital | Wuhan, Hubei, China | Recruiting |
| Renmin Hospital of Wuhan University | Wuhan, Hubei, China | Recruiting |
+ 22 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04790305